<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "3: competitive", fill: "#fc89ac"},
{source: "3: competitive", target: "3: conditions", fill: "#fc89ac"},
{source: "3: conditions", target: "3: operations", fill: "#fc89ac"},
{source: "3: competitive", target: "4: significant sales", fill: "#fe4164"},
{source: "4: significant sales", target: "4: development", fill: "#fe4164"},
{source: "4: development", target: "4: manufacturing costs", fill: "#fe4164"},
{source: "4: significant sales", target: "11: optoelectronic devices", fill: "#e6e200"},
{source: "11: optoelectronic devices", target: "11: electronics", fill: "#e6e200"},
{source: "11: electronics", target: "11: manufacturing", fill: "#e6e200"},
{source: "11: manufacturing", target: "11: competition", fill: "#e6e200"},
{source: "11: competition", target: "11: development", fill: "#e6e200"},
{source: "11: development", target: "11: product quality timeliness", fill: "#e6e200"},
{source: "11: product quality timeliness", target: "11: delivery price customer technical support", fill: "#e6e200"},
{source: "11: delivery price customer technical support", target: "11: design through volume subsystem production", fill: "#e6e200"},
{source: "11: optoelectronic devices", target: "21: inspection systems fail", fill: "#cf0"},
{source: "21: inspection systems fail", target: "21: product liability", fill: "#cf0"},
{source: "21: product liability", target: "21: adequate insurance coverage", fill: "#cf0"},
{source: "21: inspection systems fail", target: "32: addition there", fill: "#a99a86"},
{source: "32: addition there", target: "32: factors beyond", fill: "#a99a86"},
{source: "32: factors beyond", target: "32: liability", fill: "#a99a86"},
{source: "32: addition there", target: "39: businesses", fill: "#b5a642"},
{source: "39: businesses", target: "39: liability", fill: "#b5a642"},
{source: "39: liability", target: "39: andor product recalls", fill: "#b5a642"},
{source: "39: businesses", target: "112: comply with environmental regulations may", fill: "#6e7f80"},
{source: "112: comply with environmental regulations may", target: "112: environmental", fill: "#6e7f80"},
{source: "112: environmental", target: "112: significant", fill: "#6e7f80"},
{source: "112: significant", target: "112: liabilities", fill: "#6e7f80"},
{source: "112: liabilities", target: "112: manufacturing", fill: "#6e7f80"},
{source: "112: comply with environmental regulations may", target: "139: Our Articles of Incorporation ", fill: "#915f6d"},
{source: "139: Our Articles of Incorporation ", target: "139: Board of Directors ", fill: "#915f6d"},
{source: "139: Board of Directors ", target: "139: of Preferred Stock ", fill: "#915f6d"},
{source: "139: of Preferred Stock ", target: "139: preferences", fill: "#915f6d"},
{source: "139: preferences", target: "139: restrictions", fill: "#915f6d"},
{source: "139: restrictions", target: "139: imposed upon", fill: "#915f6d"},
{source: "139: imposed upon", target: "139: wholly unissued shares", fill: "#915f6d"},
{source: "139: wholly unissued shares", target: "139: to or Preferred Stock ", fill: "#915f6d"},
{source: "139: to or Preferred Stock ", target: "139: constituting", fill: "#915f6d"},
{source: "139: constituting", target: "139: designation", fill: "#915f6d"},
{source: "139: designation", target: "139: without further vote", fill: "#915f6d"},
{source: "139: without further vote", target: "139: action by shareholders", fill: "#915f6d"},
{source: "139: Our Articles of Incorporation ", target: "142: concentration", fill: "#ffe5b4"},
{source: "142: concentration", target: "142: directors", fill: "#ffe5b4"},
{source: "142: directors", target: "142: officers could discourage certain types", fill: "#ffe5b4"},
{source: "142: officers could discourage certain types", target: "142: transactions", fill: "#ffe5b4"},
{source: "142: transactions", target: "142: Common Stock", fill: "#ffe5b4"},
{source: "142: Common Stock", target: "142: shares over then current prices", fill: "#ffe5b4"},
{source: "142: shares over then current prices", target: "142: otherwise dilute", fill: "#ffe5b4"},
{source: "142: otherwise dilute", target: "142: shareholders", fill: "#ffe5b4"},
{source: "142: concentration", target: "START_HERE", fill: "#ffe5b4"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Consumer Electronics</td>
    </tr>
    <tr>
      <td>Computer and Electronics Retail</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Investment Banking and Brokerage</td>
    </tr>
    <tr>
      <td>Automobiles and Components</td>
    </tr>
    <tr>
      <td>Electrical Components and Equipment</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Environmental Services</td>
    </tr>
    <tr>
      <td>Independent Power Producers and Energy Traders</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Demonstrate</td>
    </tr>
    <tr>
      <td>Yield position</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Military blockade</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Psychological state</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Propose</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arithmetic">Arithmetic</a></td>
      <td>Arithmetic (from Ancient Greek  ἀριθμός (arithmós) 'number', and  τική [τέχνη] (tikḗ [tékhnē]) 'art, craft') is an elementary part of mathematics that consists of the study of the properties of the traditional operations on numbers—addition, subtraction, multiplication, division, exponentiation, and extraction of roots. In the 19th century, Italian mathematician Giuseppe Peano formalized arithmetic with his Peano axioms, which are highly important to the field of mathematical logic today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_management">Operations management</a></td>
      <td>Operations management is an area of management concerned with designing and controlling the process of production and redesigning business operations in the production of goods or services. It involves the responsibility of ensuring that business operations are efficient in terms of using as few resources as needed and effective in meeting customer requirements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Surgery">Surgery</a></td>
      <td>Surgery is a medical or dental specialty that uses operative manual and instrumental techniques on a person to investigate or treat a pathological condition such as a disease or injury, to help improve bodily function, appearance, or to repair unwanted ruptured areas.\nThe act of performing surgery may be called a surgical procedure, operation, or simply "surgery".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_(mathematics)">Operation (mathematics)</a></td>
      <td>In mathematics, an operation is a function which takes zero or more input values (called operands) to a well-defined output value. The number of operands (also known as arguments) is the arity of the operation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arrested_Development">Arrested Development</a></td>
      <td>Arrested Development is an American television sitcom created by Mitchell Hurwitz, which originally aired on Fox for three seasons from  2003 to 2006, followed by a two-season revival on Netflix from 2013 to 2019. The show follows the Bluths, a formerly wealthy dysfunctional family.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Sustainable_development">Sustainable development</a></td>
      <td>Sustainable development is an organizing principle for meeting human development goals while also sustaining the ability of natural systems to provide the natural resources and ecosystem services on which the economy and society depend. The desired result is a state of society where living conditions and resources are used to continue to meet human needs without undermining the integrity and stability of the natural system.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Software_development">Software development</a></td>
      <td>Software development is the process of conceiving, specifying, designing, programming, documenting, testing, and bug fixing involved in creating and maintaining applications, frameworks, or other software components. Software development involves writing and maintaining the source code, but in a broader sense, it includes all processes from the conception of the desired software through to the final manifestation of the software, typically in a planned and structured process.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Management_development">Management development</a></td>
      <td>Management development is the process by which managers learn and improve their management skills.\n\n\n== Background ==\nIn organisational development, management effectiveness is recognized as a determinant of organisational success.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Manufacturing">Manufacturing</a></td>
      <td>Manufacturing is the creation or production of goods with the help of equipment, labor, machines, tools, and chemical or biological processing or formulation. It is the essence of secondary sector of the economy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Automotive_industry">Automotive industry</a></td>
      <td>The automotive industry comprises a wide range of companies and organizations involved in the design, development, manufacturing, marketing, and selling of motor vehicles. It is one of the world's largest industries by revenue (from 16 % such as in France up to 40 % to countries like Slovakia).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Product_liability">Product liability</a></td>
      <td>Product liability is the area of law in which manufacturers, distributors, suppliers, retailers, and others who make products available to the public are held responsible for the injuries those products cause. Although the word "product" has broad connotations, product liability as an area of law is traditionally limited to products in the form of tangible personal property.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Legal_liability">Legal liability</a></td>
      <td>In law, liable means  "responsible or answerable in law; legally obligated". Legal liability concerns both civil law and criminal law and can arise from various areas of law, such as contracts, torts, taxes, or fines given by government agencies.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Liability_insurance">Liability insurance</a></td>
      <td>Liability insurance (also called third-party insurance) is a part of the general insurance system of risk financing to protect the purchaser (the "insured") from the risks of liabilities imposed by lawsuits and similar claims and protects the insured if the purchaser is sued for claims that come within the coverage of the insurance policy.\nOriginally, individual companies that faced a common peril formed a group and created a self-help fund out of which to pay compensation should any member incur loss (in other words, a mutual insurance arrangement).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Limited_liability_company">Limited liability company</a></td>
      <td>A limited liability company (LLC) is the US-specific form of a private limited company. It is a business structure that can combine the pass-through taxation of a partnership or sole proprietorship with the limited liability of a corporation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Limited_liability">Limited liability</a></td>
      <td>Limited liability is a legal status where a person's financial liability is limited to a fixed sum, most commonly the value of a person's investment in a corporation, company or partnership. If a company that provides limited liability to its investors is sued, then the claimants are generally entitled to collect only against the assets of the company, not the assets of its shareholders or other investors.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/No_liability">No liability</a></td>
      <td>A no-liability company in Australia (suffix NL) is a company which, under the Corporations Act 2001 (Cth), must have as its stated objects that it is solely a mining company and that it is not entitled to calls on the unpaid issue price of shares. It is a company which is restricted to mining activities and is the only sort of corporation which is entitled to this form of liability, given the sometimes financially risky business of mining.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Limited_liability_partnership">Limited liability partnership</a></td>
      <td>A limited liability partnership (LLP) is a partnership in which some or all partners (depending on the jurisdiction) have limited liabilities. It therefore can exhibit elements of partnerships and corporations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Vicarious_liability">Vicarious liability</a></td>
      <td>Vicarious liability is a form of a  strict, secondary liability that arises under the common law doctrine of agency, respondeat superior, the responsibility of the superior for the acts of their subordinate or, in a broader sense, the responsibility of any third party that had the "right, ability or duty to control" the activities of a violator. It can be distinguished from contributory liability, another form of secondary liability, which is rooted in the tort theory of enterprise liability because, unlike contributory infringement, knowledge is not an element of vicarious liability.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business">Business</a></td>
      <td>Business is the activity of making one's living or making money by producing or buying and selling products (such as goods and services). It is also "any activity or enterprise entered into for profit."Having a business name does not separate the business entity from the owner, which means that the owner of the business is responsible and liable for debts incurred by the business.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_Insider">Business Insider</a></td>
      <td>Insider – previously named Business Insider (BI) – is an American financial and business news website founded in 2007. Since 2015, a majority stake in Business Insider's parent company Insider Inc.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Small_business">Small business</a></td>
      <td>Small businesses are  corporations, partnerships, or sole proprietorships which have fewer employees and/or less annual revenue than a regular-sized business or corporation. Businesses are defined as "small" in terms of being able to apply for government support and qualify for preferential tax policy varies depending on the country and industry.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_administration">Business administration</a></td>
      <td>Business administration (also known as business management) is the administration of a  commercial enterprise. It includes all aspects of overseeing and supervising business operations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_Is_Business">Business Is Business</a></td>
      <td>Business-to-business (B2B or, in some countries, BtoB) is a situation where one business makes a commercial transaction with another. This typically occurs when:\n\nA business is sourcing materials for their production process for output   (e.g., a food manufacturer purchasing salt), i.e.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_intelligence">Business intelligence</a></td>
      <td>Business intelligence (BI) comprises the strategies and technologies used by enterprises for the data analysis and management of business information. Common functions of business intelligence technologies include reporting, online analytical processing, analytics, dashboard development, data mining, process mining, complex event processing, business performance management, benchmarking, text mining, predictive analytics, and prescriptive analytics.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_Proposal">Business Proposal</a></td>
      <td>Business Proposal (Korean: 사내 맞선; Hanja: 社內맞선; RR: Sanae Matseon; lit. The Office Blind Date) is a South Korean romantic comedy television series based on the webtoon of the same title written by HaeHwa and illustrated by Narak.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Equity_(finance)">Equity (finance)</a></td>
      <td>In finance, equity is ownership of assets that may have debts or other liabilities attached to them. Equity is measured for accounting purposes by subtracting liabilities from the value of the assets.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Shareholder">Shareholder</a></td>
      <td>A shareholder (in the United States often referred to as stockholder) of a corporation is an individual or legal entity (such as another corporation, a body politic, a trust or partnership) that is registered by the corporation as the legal owner of shares of the share capital of a public or private corporation. Shareholders may be referred to as members of a corporation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Activist_shareholder">Activist shareholder</a></td>
      <td>An activist shareholder is a shareholder who uses an equity stake in a corporation to put pressure on its management. A fairly small stake (less than 10% of outstanding shares) may be enough to launch a successful campaign.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Shareholders'_agreement">Shareholders' agreement</a></td>
      <td>A shareholders' agreement (sometimes referred to in the U.S. as a stockholders' agreement) (SHA) is an agreement amongst the shareholders or members of a company. In practical effect, it is analogous to a partnership agreement.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Annual_general_meeting">Annual general meeting</a></td>
      <td>An annual general meeting (AGM, also known as the annual meeting) is a meeting of the general membership of an organization.\nThese organizations include membership associations and companies with shareholders.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Given the nature of the markets in which we <font color="blue">participate</font>, we <font color="blue">cannot reliably</font>     <font color="blue">predict future revenues</font> and <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>Changes in <font color="blue">competitive</font>, market     and  economic <font color="blue">conditions</font> may cause us to adjust our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>A high     proportion of our costs are fixed, due in part to our <font color="blue"><font color="blue">significant</font> sales</font>,     research and <font color="blue">development</font> and <font color="blue"><font color="blue">manufacturing</font> costs</font></td>
    </tr>
    <tr>
      <td>Thus, small declines in     <font color="blue">revenue could disproportionately affect</font> our operating results</td>
    </tr>
    <tr>
      <td>Factors that     may affect our operating results and the <font color="blue">market price</font> of our <font color="blue"><font color="blue"><font color="blue">Common Stock</font> </font>    </font>include:           •   demand for and <font color="blue">market acceptance</font> of our products;           •   <font color="blue">competitive</font> pressures resulting in lower selling prices;           •   adverse changes in the level of <font color="blue">economic activity</font> in regions in which     we do business;           •   low or <font color="blue">fluctuating levels</font> of <font color="blue">political stability</font> in regions in which     we do business;           •   adverse changes in industries, such as semiconductors and <font color="blue">electronics</font>,     on which we are <font color="blue"><font color="blue">particularly</font> <font color="blue">dependent</font></font>;           •   changes in the portions of our <font color="blue">revenue represented by various products</font>     and customers;           •   delays or problems in the <font color="blue">introduction</font> of <font color="blue">new products</font>;           •   the <font color="blue">announcement</font> or <font color="blue">introduction</font> of <font color="blue">new products</font>, services or     <font color="blue"><font color="blue">technological</font> innovations by</font> our <font color="blue">competitors</font>;           •   <font color="blue">variations</font> in our <font color="blue">product mix</font>;                                           21     ______________________________________________________________________    [49]Table of <font color="blue">Contents       </font>  •   the timing and amount of our <font color="blue">expenditures</font> in <font color="blue">anticipation</font> of future     sales;           •   exchange rate <font color="blue">fluctuations</font>;           •   increased costs of raw materials or supplies;           •   changes in the volume or timing of <font color="blue">product orders</font>;           •   timing of <font color="blue">completion</font> of <font color="blue">acceptance testing</font> of some of our products;           •   <font color="blue">natural disasters</font>; and           •   changes in <font color="blue">general economic factors</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">face aggressive <font color="blue">competition</font></font> in many areas of business</td>
    </tr>
    <tr>
      <td>If we do not     <font color="blue">compete <font color="blue">effectively</font></font>, our business will be harmed</td>
    </tr>
    <tr>
      <td>In the security and inspection and <font color="blue">medical monitoring</font> and     <font color="blue">anesthesia systems</font> markets, <font color="blue">competition</font> is based primarily on such factors     as product performance, <font color="blue">functionality</font> and quality, cost, prior customer     <font color="blue">relationships</font>,  <font color="blue">technological</font>  <font color="blue">capabilities</font>  of  the  product,  price,     <font color="blue">certification</font> by <font color="blue">government</font> <font color="blue">authorities</font>, local market presence and breadth     of  sales  and service <font color="blue">organization</font></td>
    </tr>
    <tr>
      <td>In the <font color="blue">opto<font color="blue">electronic devices</font></font> and     <font color="blue">electronics</font> <font color="blue">manufacturing</font> markets <font color="blue">competition</font> is based primarily on factors     such as expertise in the design and <font color="blue">development</font> of <font color="blue">opto<font color="blue">electronic devices</font></font>,     product quality, timeliness of delivery, price, customer technical support     and on the ability to provide fully-integrated services from application     <font color="blue">development</font> and <font color="blue">design through volume subsystem production</font></td>
    </tr>
    <tr>
      <td>We may not be     able  to  compete  <font color="blue">effectively</font>  with all of our <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>To remain     <font color="blue">competitive</font>, we must develop <font color="blue">new products</font> and enhance our <font color="blue">existing products</font>     and services in a <font color="blue">timely manner</font></td>
    </tr>
    <tr>
      <td>We anticipate that we may have to adjust     prices  of  many of our products to stay <font color="blue">competitive</font></td>
    </tr>
    <tr>
      <td>In addition, new     <font color="blue">competitors</font> may emerge, and <font color="blue">entire <font color="blue">product lines</font></font> or <font color="blue">service offerings</font> may be     <font color="blue">threatened by <font color="blue">new <font color="blue">technologies</font></font></font> or <font color="blue">market trends</font> that reduce the value of     these <font color="blue">product lines</font> or <font color="blue">service offerings</font></td>
    </tr>
    <tr>
      <td>The  September 11, 2001 terrorist attacks and the creation of the US     Department of Homeland Security have <font color="blue">increased financial expectations</font> that     may not <font color="blue">materialize</font></td>
    </tr>
    <tr>
      <td><font color="blue">The September </font>11, 2001 terrorist attacks and the <font color="blue">subsequent creation</font> of the     <font color="blue">US Department of Homeland Security </font>have created <font color="blue">increased interest</font> in our     security and <font color="blue">inspection systems</font>, however, we are not <font color="blue">certain whether</font> the     level of demand <font color="blue">will continue</font> to be as high as it is now</td>
    </tr>
    <tr>
      <td>Additionally, should our products be considered     as a part of the <font color="blue">future security solution</font>, it is unclear what the level may     be and <font color="blue">how quickly funding</font> to purchase our <font color="blue">products may</font> be made available</td>
    </tr>
    <tr>
      <td>These  factors  <font color="blue">may <font color="blue">adversely</font> impact us</font> and create <font color="blue">unpredictability</font> in     revenues and operating results</td>
    </tr>
    <tr>
      <td>If operators of our security and <font color="blue"><font color="blue">inspection systems</font> fail</font> to detect weapons,     explosives or other devises that are used to commit a terrorist act, we     could be exposed to <font color="blue">product <font color="blue">liability</font></font> and related claims for which we may     not have <font color="blue">adequate insurance coverage</font></td>
    </tr>
    <tr>
      <td>Our  business <font color="blue">exposes us</font> to potential <font color="blue">product <font color="blue">liability</font></font> risks that are     inherent in the <font color="blue">development</font>, <font color="blue">manufacturing</font>, sale and service of security     <font color="blue">inspection systems</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">customers use</font> our security and <font color="blue">inspection systems</font> to     help them detect items that could be used in performing terrorist acts or     other crimes</td>
    </tr>
    <tr>
      <td>Others signal to the operator that further     <font color="blue">investigation</font> is required</td>
    </tr>
    <tr>
      <td>In <font color="blue">either case</font>, the training, <font color="blue">re<font color="blue">liability</font></font> and     competence  of  the customer’s operator is crucial to the <font color="blue">detection</font> of     <font color="blue">suspicious items</font></td>
    </tr>
    <tr>
      <td>Furthermore, security inspection by <font color="blue">technological</font> means is     circumstance  and  application-specific</td>
    </tr>
    <tr>
      <td>In addition, our security and     <font color="blue">inspection systems</font> are not designed to work under all <font color="blue">circumstances</font></td>
    </tr>
    <tr>
      <td>We test     the <font color="blue">re<font color="blue">liability</font></font> of                                           22     ______________________________________________________________________    [50]Table of <font color="blue">Contents       </font>our  security and <font color="blue">inspection systems</font> during both their <font color="blue">development</font> and     <font color="blue">manufacturing</font> phases</td>
    </tr>
    <tr>
      <td>We also perform <font color="blue">such tests</font> if we are requested to     perform installation, warranty or post-warranty servicing</td>
    </tr>
    <tr>
      <td>However, our     security <font color="blue">inspection systems</font> are <font color="blue">advanced mechanical</font> and <font color="blue">electronic devices</font>     and  therefore can <font color="blue">malfunction</font></td>
    </tr>
    <tr>
      <td>In addition, there are also many other     <font color="blue">factors beyond</font> our control that could lead to <font color="blue">liability</font> claims should an act     of terrorism occur</td>
    </tr>
    <tr>
      <td><font color="blue">The September </font>11, 2001 and 1993 <font color="blue">World Trade Center     </font>bombing  attacks,  and  the  potential for <font color="blue">future attacks</font>, have caused     <font color="blue">commercial insurance</font> for <font color="blue">such threats</font> to <font color="blue">become extremely difficult</font> to     obtain</td>
    </tr>
    <tr>
      <td>It is very likely that, should we be <font color="blue">found liable following</font> a major     act of terrorism, the insurance we currently have in place would not fully     cover the claims for damages</td>
    </tr>
    <tr>
      <td>Our <font color="blue">medical monitoring</font> and <font color="blue"><font color="blue">anesthesia systems</font> could give rise</font> to product     <font color="blue">liability</font> claims that <font color="blue">could materially</font> and <font color="blue"><font color="blue">adversely</font> affect</font> our financial     condition and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">development</font>, <font color="blue">manufacturing</font> and sale of <font color="blue"><font color="blue">medical devices</font> expose us</font> to     <font color="blue"><font color="blue">significant</font> risk</font> of <font color="blue">product <font color="blue">liability</font></font> claims and, sometimes, product failure     claims</td>
    </tr>
    <tr>
      <td>We face an inherent business risk of <font color="blue">financial exposure</font> to product     <font color="blue">liability</font> claims if the use of our <font color="blue">medical devices</font> results in personal     injury or death</td>
    </tr>
    <tr>
      <td><font color="blue">Substantial </font><font color="blue">product <font color="blue">liability</font></font> <font color="blue">litigation</font> currently exists     within the medical device industry</td>
    </tr>
    <tr>
      <td>Some of our <font color="blue">medical monitoring</font> and     <font color="blue">anesthesia systems</font> <font color="blue">businesses</font> have, in the past, been subject to product     <font color="blue">liability</font> claims and/or product recalls</td>
    </tr>
    <tr>
      <td>To date, no such claim or recall     has had a <font color="blue"><font color="blue">significant</font> impact on</font> our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Future <font color="blue">product <font color="blue">liability</font></font>     claims may exceed the limits of our <font color="blue">insurance coverages</font> or <font color="blue">such insurance</font>     may not continue to be available to <font color="blue">us on commercially reasonable terms</font>, or     at all</td>
    </tr>
    <tr>
      <td>Consequently, a <font color="blue">product <font color="blue">liability</font></font> claim or other claim <font color="blue">with respect</font>     to <font color="blue">uninsured <font color="blue">liabilities</font></font>, or in excess of insured <font color="blue">liabilities</font>, could have a     material adverse effect on our business, <font color="blue">financial condition</font>, operating     results and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>Our revenues are <font color="blue"><font color="blue">dependent</font> on orders</font> of security and <font color="blue">inspection systems</font> and     medical  monitoring and <font color="blue">anesthesia systems</font>, which may have lengthy and     <font color="blue">unpredictable sales cycles</font></td>
    </tr>
    <tr>
      <td>Sales of security and <font color="blue">inspection systems</font> often depend upon the decision of     <font color="blue">government</font>al  agencies  to upgrade or expand existing airports, border     crossing inspection sites, seaport inspection sites and other security     <font color="blue">installations</font></td>
    </tr>
    <tr>
      <td>Sales outside of the <font color="blue"><font color="blue">United States</font> </font>of our <font color="blue">medical monitoring</font>     and  anesthesia  systems depend in <font color="blue">significant</font> part on the decision of     <font color="blue">government</font>al agencies to build new medical <font color="blue">facilities</font> or to expand or update     existing medical <font color="blue">facilities</font></td>
    </tr>
    <tr>
      <td>Accordingly, a <font color="blue">significant</font> portion of our sales     of security and <font color="blue">inspection systems</font> and our <font color="blue">medical monitoring</font> and anesthesia     systems is often subject to delays associated with the lengthy approval     processes that typically <font color="blue">accompany</font> such capital <font color="blue">expenditures</font></td>
    </tr>
    <tr>
      <td>During these     <font color="blue">approval periods</font>, we expend <font color="blue">significant</font> financial and <font color="blue"><font color="blue">management</font> resources</font>     in <font color="blue">anticipation</font> of <font color="blue">future orders</font> that may not occur</td>
    </tr>
    <tr>
      <td>If we fail to receive     an order after expending such resources, such failure could have a material     adverse  effect  on  our  business, <font color="blue">financial condition</font> and results of     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>If we do not introduce <font color="blue">new products</font> in a <font color="blue">timely manner</font>, our <font color="blue">products could</font>     <font color="blue">become obsolete</font> and our operating results <font color="blue">would suffer</font></td>
    </tr>
    <tr>
      <td>We  sell  many  of  our  products in <font color="blue">industries characterized by rapid</font>     <font color="blue">technological</font> changes, <font color="blue">frequent new product</font> and service <font color="blue">introduction</font>s and     evolving  industry  standards  and  customer needs</td>
    </tr>
    <tr>
      <td>Without the timely     <font color="blue">introduction</font> of <font color="blue">new products</font> and <font color="blue">enhancements</font>, our <font color="blue">products could</font> become     <font color="blue">technological</font>ly obsolete over time, in which case our revenue and operating     results <font color="blue">would suffer</font></td>
    </tr>
    <tr>
      <td>The success of our <font color="blue">new product offerings will depend</font>     <font color="blue">upon several factors</font>, including our ability to:           •   <font color="blue">accurately</font> anticipate customer needs;           •   innovate and develop <font color="blue">new <font color="blue">technologies</font></font> and <font color="blue">applications</font>;           •   <font color="blue">successfully</font> commercialize <font color="blue">new <font color="blue">technologies</font></font> in a <font color="blue">timely manner</font>;           •   price our products <font color="blue">competitive</font>ly and <font color="blue">manufacture</font> and deliver our     products in <font color="blue">sufficient volumes</font> and on time; and           •   differentiate our <font color="blue">offerings from</font> our <font color="blue">competitors</font>’ offerings</td>
    </tr>
    <tr>
      <td>23     ______________________________________________________________________    [51]Table of <font color="blue">Contents       </font>Some  of  our  products are used by our customers to develop, test and     <font color="blue">manufacture</font> their products</td>
    </tr>
    <tr>
      <td>We therefore must anticipate industry trends and     develop products in advance of the <font color="blue">commercialization</font> of our customers’     products</td>
    </tr>
    <tr>
      <td>In developing any new product, we may be required to make a     substantial <font color="blue">investment</font> before we can determine the commercial viability of     the new product</td>
    </tr>
    <tr>
      <td>If we fail to <font color="blue">accurately</font> foresee our customers’ needs and     <font color="blue">future <font color="blue">activities</font></font>, we <font color="blue">may invest heavily</font> in research and <font color="blue">development</font> of     products that do not lead to <font color="blue">significant</font> revenues</td>
    </tr>
    <tr>
      <td><font color="blue">Interruptions </font>in our ability to purchase raw materials and <font color="blue">components</font> may     <font color="blue"><font color="blue">adversely</font> affect</font> our <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">purchase certain raw materials</font> and sub<font color="blue">components</font> from third parties     pursuant to <font color="blue">purchase orders placed from</font> time to time</td>
    </tr>
    <tr>
      <td>Purchase order terms     <font color="blue">range from three months</font> to <font color="blue">one year at</font> fixed costs, but we do not have     guaranteed long-term supply arrangements with our suppliers</td>
    </tr>
    <tr>
      <td>Any material     interruption  in  our  ability  to <font color="blue">purchase <font color="blue">necessary</font> raw materials</font> or     sub<font color="blue">components</font>  could  have  a material adverse effect on our business,     <font color="blue">financial condition</font> and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We may not be able to <font color="blue">successfully</font> implement our <font color="blue"><font color="blue"><font color="blue">acquisition</font>s</font> strategy</font>,     integrate acquired <font color="blue">businesses</font> into our existing business or make acquired     <font color="blue">businesses</font> profitable</td>
    </tr>
    <tr>
      <td>One of our strategies is to supplement our internal growth by acquiring     <font color="blue">businesses</font> and <font color="blue">technologies</font> that <font color="blue">complement</font> or augment our existing product     lines</td>
    </tr>
    <tr>
      <td>This growth has placed, and <font color="blue">may continue</font> to place, <font color="blue">significant</font>     <font color="blue">demands on</font> our <font color="blue">management</font>, working capital and <font color="blue">financial resources</font></td>
    </tr>
    <tr>
      <td>We may     be unable to identify or complete <font color="blue">promising <font color="blue"><font color="blue">acquisition</font>s</font></font> for many reasons,     including:           •   <font color="blue">competition</font> among buyers;           •   the need for <font color="blue"><font color="blue">regulatory</font> approvals</font>, including <font color="blue">antitrust approvals</font>; and           •   the high valuations of <font color="blue">businesses</font></td>
    </tr>
    <tr>
      <td>Some of the <font color="blue">businesses</font> we may seek to acquire may be marginally profitable     or unprofitable</td>
    </tr>
    <tr>
      <td>For these acquired <font color="blue">businesses</font> to achieve acceptable levels     of <font color="blue">profitability</font>, we must improve their <font color="blue">management</font>, <font color="blue">operations</font>, products and     market  <font color="blue">penetration</font></td>
    </tr>
    <tr>
      <td>We  may not be successful in this regard and may     encounter other <font color="blue">difficulties</font> in integrating acquired <font color="blue">businesses</font> into our     existing <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>To finance our <font color="blue"><font color="blue">acquisition</font>s</font>, we may have to raise additional funds, through     either public or <font color="blue">private financings</font></td>
    </tr>
    <tr>
      <td>We may be unable to obtain such funds     or may be able to do so <font color="blue">only on unfavorable terms</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">acquisition</font> and <font color="blue">alliance <font color="blue">activities</font> could disrupt</font> our ongoing business</td>
    </tr>
    <tr>
      <td>We  intend  to continue to make <font color="blue">investment</font>s in companies, products and     <font color="blue">technologies</font>,  either  through <font color="blue"><font color="blue">acquisition</font>s</font>, <font color="blue">investment</font>s or alliances</td>
    </tr>
    <tr>
      <td><font color="blue">Acquisition  </font>and  alliance  <font color="blue">activities</font> often involve risks, including:     (i) <font color="blue">difficulty</font>  in <font color="blue">assimilating</font> the acquired <font color="blue">operations</font> and employees;     (ii) <font color="blue">difficulty</font> in managing product co-<font color="blue">development</font> <font color="blue">activities</font> with our     alliance partners; (iii) <font color="blue">difficulty</font> in retaining the <font color="blue">key employees</font> of the     acquired operation; (iv) disruption of our ongoing business; (v) inability     to <font color="blue">successfully</font> integrate the acquired <font color="blue">technologies</font> and <font color="blue">operations</font> into our     <font color="blue">businesses</font>  and  maintain  uniform  standards,  controls, policies and     procedures; and (vi) lacking the experience <font color="blue">necessary</font> to <font color="blue">enter into new</font>     product or technology markets <font color="blue">successfully</font></td>
    </tr>
    <tr>
      <td>In addition, from time to time,     our <font color="blue">competitors</font> acquire or <font color="blue">enter into exclusive arrangements with companies</font>     with whom we do business or may do business in the future</td>
    </tr>
    <tr>
      <td><font color="blue">Reductions </font>in the     number of partners with whom we may do business in a <font color="blue">particular context may</font>     reduce our ability to <font color="blue">enter into critical alliances on attractive terms</font> or     at all, and the <font color="blue">termination</font> of an <font color="blue">existing alliance by</font> a business partner     <font color="blue">may disrupt</font> our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>24     ______________________________________________________________________    [52]Table of <font color="blue">Contents       </font>Economic, political and other <font color="blue">risks associated with international sales</font> and     <font color="blue">operations</font> could <font color="blue"><font color="blue">adversely</font> affect</font> our sales</td>
    </tr>
    <tr>
      <td>In <font color="blue">fiscal year</font> 2004, revenues from shipments made outside of the United     States accounted for <font color="blue">approximately</font> 41prca of our revenues, 40prca in <font color="blue">fiscal year</font>     2005 and 42prca in <font color="blue">fiscal year</font> 2006</td>
    </tr>
    <tr>
      <td>Of the revenues generated during fiscal     year 2006 from shipments made to customers outside of the <font color="blue">United States</font>, 46prca     represented sales made by <font color="blue">subsidiaries</font> based in <font color="blue"><font color="blue">United States</font> </font>to foreign     customers,  and  the  balance  represented  sales generated by foreign     <font color="blue">subsidiaries</font></td>
    </tr>
    <tr>
      <td>Since  we  sell  certain of our <font color="blue">products worldwide</font>, our     <font color="blue">businesses</font>  are  subject  to  risks  associated  with  doing  business     <font color="blue">internationally</font></td>
    </tr>
    <tr>
      <td>We anticipate that revenues from international <font color="blue">operations</font>     <font color="blue">will continue</font> to represent a substantial portion of our <font color="blue">total revenue</font></td>
    </tr>
    <tr>
      <td>In     addition, many of our <font color="blue">manufacturing</font> <font color="blue">facilities</font>, and therefore employees,     suppliers, real property, capital equipment, cash and other assets are     <font color="blue">located outside</font> the <font color="blue">United States</font></td>
    </tr>
    <tr>
      <td>Accordingly, our future results could be     <font color="blue">harmed by</font> a variety of factors, including:           •   changes in <font color="blue">foreign currency exchange rates</font>;           •   changes in a country’s or region’s political or economic <font color="blue">conditions</font>,     <font color="blue">particularly</font> in developing or <font color="blue">emerging markets</font>;           •   <font color="blue">longer payment cycles</font> of <font color="blue">foreign customers</font> and <font color="blue">difficulty</font> of     <font color="blue">collecting receivables</font> in <font color="blue">foreign jurisdictions</font>;           •   <font color="blue">trade protection measures</font> and import or <font color="blue">export licensing <font color="blue">requirements</font></font>;           •   <font color="blue">differing legal</font> and <font color="blue">court systems</font>;           •   <font color="blue">differing tax laws</font> and changes in those laws;           •   <font color="blue">difficulty</font> in staffing and managing widespread <font color="blue">operations</font>;           •   <font color="blue">differing labor laws</font> and changes in those laws;           •   <font color="blue">differing protection</font> of <font color="blue"><font color="blue">intellectual</font> property</font> and changes in that     protection; and           •   differing <font color="blue">regulatory</font> <font color="blue">requirements</font> and changes in those <font color="blue">requirements</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">products may</font> infringe on the <font color="blue"><font color="blue">intellectual</font> property</font> rights of others, and     resulting claims against us could be costly and prevent us from making or     <font color="blue">selling certain products</font></td>
    </tr>
    <tr>
      <td>Third <font color="blue">parties may seek</font> to claim that our products and <font color="blue">operations</font> infringe     their patent or other <font color="blue"><font color="blue">intellectual</font> property</font> rights</td>
    </tr>
    <tr>
      <td>In addition, we may find     it <font color="blue">necessary</font> to <font color="blue">initiate <font color="blue">litigation</font></font> in order to protect our patent or other     <font color="blue">intellectual</font>  <font color="blue">property rights</font></td>
    </tr>
    <tr>
      <td>Under either circumstance, we may incur     <font color="blue">significant</font> expenses</td>
    </tr>
    <tr>
      <td>Our <font color="blue">competitors</font> may seek to challenge the <font color="blue"><font color="blue">intellectual</font> property</font> rights on     which some of our new and more <font color="blue">promising products</font> are based</td>
    </tr>
    <tr>
      <td>As  we  introduce any new and potentially promising product, companies     possessing competing <font color="blue">technologies</font> may be motivated to assert <font color="blue">infringement</font>     claims in order to delay or <font color="blue">diminish potential sales</font> and challenge our right     to <font color="blue">market such product</font></td>
    </tr>
    <tr>
      <td>Lengthy and costly <font color="blue">litigation</font> may be <font color="blue">necessary</font> in     order to defend against these claims</td>
    </tr>
    <tr>
      <td>Our <font color="blue">ongoing success</font> is <font color="blue"><font color="blue">dependent</font> upon</font> the <font color="blue">continued <font color="blue">availability</font></font> of certain     <font color="blue">key employees</font></td>
    </tr>
    <tr>
      <td>We are <font color="blue">dependent</font> in our <font color="blue">operations</font> on the <font color="blue">continued <font color="blue">availability</font></font> of the     services of our employees, many of whom are <font color="blue">individually key</font> to our current     and <font color="blue">future success</font>, and the <font color="blue">availability</font> of new employees to implement our     growth plans</td>
    </tr>
    <tr>
      <td>In particular, we are <font color="blue"><font color="blue">dependent</font> upon</font> the services of Deepak     Chopra,  our  Chairman  of the Board of Directors, President and Chief     Executive Officer</td>
    </tr>
    <tr>
      <td>We have entered into a 5-year employment agreement                                           25     ______________________________________________________________________    [53]Table of <font color="blue">Contents       </font>with Mr</td>
    </tr>
    <tr>
      <td>Chopra, <font color="blue">which expires</font> July 18, 2010 and we maintain a dlra13dtta0 million     policy of <font color="blue">key man life insurance on</font> the life of Mr</td>
    </tr>
    <tr>
      <td>The market for     skilled  employees  is highly <font color="blue">competitive</font>, especially for employees in     <font color="blue">technical fields</font></td>
    </tr>
    <tr>
      <td>While our <font color="blue">compensation programs</font> are intended to attract     and retain the employees required for it to be successful, ultimately, we     may not be able to retain the services of all of our <font color="blue">key employees</font> or a     sufficient number to execute on our plans</td>
    </tr>
    <tr>
      <td>In addition, we may not be able     to continue to <font color="blue">attract new employees as</font> required</td>
    </tr>
    <tr>
      <td><font color="blue">Substantial </font> <font color="blue">government</font> regulation in the <font color="blue"><font color="blue">United States</font> </font>and abroad may     restrict our ability to sell our <font color="blue">medical monitoring</font> and <font color="blue">anesthesia systems</font></td>
    </tr>
    <tr>
      <td>The  FDA  and  comparable  <font color="blue">regulatory</font> <font color="blue">authorities</font> in <font color="blue">foreign countries</font>     <font color="blue">extensively</font> and <font color="blue">rigorously</font> regulate our <font color="blue">medical monitoring</font> and anesthesia     systems,  including  related  <font color="blue">development</font> <font color="blue">activities</font> and <font color="blue">manufacturing</font>     processes</td>
    </tr>
    <tr>
      <td>In the <font color="blue">United States</font>, the FDA regulates the <font color="blue">introduction</font> of     <font color="blue">medical devices</font> as well as the <font color="blue">manufacturing</font>, labeling and record-keeping     procedures for <font color="blue">such products</font></td>
    </tr>
    <tr>
      <td>We are required to:           •   obtain clearance before we can market and sell <font color="blue">medical devices</font>;           •   satisfy content <font color="blue">requirements</font> applicable to our labeling, sales and     promotional materials;           •   comply with <font color="blue">manufacturing</font> and reporting <font color="blue">requirements</font>; and           •   <font color="blue">undergo rigorous inspections</font></td>
    </tr>
    <tr>
      <td>Our future <font color="blue">products may</font> not obtain FDA clearance on a <font color="blue">timely basis</font>, or at     all</td>
    </tr>
    <tr>
      <td>Our <font color="blue">medical monitoring</font> and <font color="blue"><font color="blue">anesthesia systems</font> must also comply with</font> the     laws and <font color="blue">regulations</font> of <font color="blue">foreign countries</font> in which we develop, <font color="blue">manufacture</font>     and <font color="blue">market such product</font>s</td>
    </tr>
    <tr>
      <td>This trend is likely to continue     and the cost and time required to obtain <font color="blue">marketing clearance</font> in any given     country may increase as a result</td>
    </tr>
    <tr>
      <td>Our <font color="blue">products may</font> not obtain any <font color="blue">necessary</font>     foreign clearances on a <font color="blue">timely basis</font>, or at all</td>
    </tr>
    <tr>
      <td>Once any of our <font color="blue">medical monitoring</font> and <font color="blue">anesthesia systems</font> is cleared for     sale,  <font color="blue">regulatory</font> <font color="blue">authorities</font> may still limit the use of such product,     prevent its sale or <font color="blue">manufacture</font> or require a recall or withdrawal of such     <font color="blue">product from</font> the marketplace</td>
    </tr>
    <tr>
      <td>Following initial clearance from <font color="blue">regulatory</font>     <font color="blue">authorities</font>, we continue to be subject to extensive <font color="blue">regulatory</font> <font color="blue">requirements</font></td>
    </tr>
    <tr>
      <td>Government <font color="blue">authorities</font> can withdraw <font color="blue">marketing clearance</font> due to our failure     to comply with <font color="blue">regulatory</font> standards or due to the occurrence of unforeseen     <font color="blue">problems following initial clearance</font></td>
    </tr>
    <tr>
      <td>Ongoing <font color="blue">regulatory</font> <font color="blue">requirements</font> are     wide-ranging and govern, among other things:           •   <font color="blue">annual inspections</font> to retain CE mark for sale of products in the     European Union;           •   product <font color="blue">manufacturing</font>;           •   <font color="blue">supplier substitution</font>;           •   product changes;           •   <font color="blue">process modifications</font>;           •   medical device reporting; and           •   <font color="blue">product sales</font> and <font color="blue">distribution</font></td>
    </tr>
    <tr>
      <td>Our failure to comply with <font color="blue">environmental</font> <font color="blue">regulations</font> may create <font color="blue">significant</font>     <font color="blue">environmental</font>  <font color="blue">liabilities</font>  and  force  us to modify our <font color="blue">manufacturing</font>     processes</td>
    </tr>
    <tr>
      <td>We  are  subject  to <font color="blue">various foreign</font> and US federal, state and local     <font color="blue">environmental</font> laws, ordinances and <font color="blue">regulations</font> relating to the use, storage,     handling and disposal of <font color="blue">certain hazardous substances</font> and <font color="blue">wastes used</font> or     generated in the <font color="blue">manufacturing</font> and assembly of our products</td>
    </tr>
    <tr>
      <td>Under such     laws,  we <font color="blue">may become liable</font> for the costs of removal or <font color="blue">remediation</font> of     <font color="blue">certain hazardous substances</font> or wastes that have been or are being disposed     of                                           26     ______________________________________________________________________    [54]Table of <font color="blue">Contents       </font><font color="blue">offsite as wastes</font> or that have been or are being <font color="blue">released on</font> or in our     <font color="blue">facilities</font></td>
    </tr>
    <tr>
      <td>Such laws may impose <font color="blue">liability</font> without regard to whether we knew     of, or caused, the release of <font color="blue">such hazardous substances</font> or wastes</td>
    </tr>
    <tr>
      <td>Any     <font color="blue">failure by us</font> to <font color="blue">comply with present</font> or future <font color="blue">regulations</font> could subject us     to the imposition of substantial fines, suspension of production, alteration     of <font color="blue">manufacturing</font> processes, or cessation of <font color="blue">operations</font>, any of <font color="blue">which could</font>     have a material adverse effect on our business, <font color="blue">financial condition</font> and     results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We may be exposed to <font color="blue">potential risks</font> relating to our <font color="blue"><font color="blue">internal controls</font> over</font>     financial reporting and our ability to have our in<font color="blue">dependent</font> registered     <font color="blue"><font color="blue">public accounting firm</font> attest</font> to these controls</td>
    </tr>
    <tr>
      <td>As <font color="blue">directed by</font> the Sarbanes-Oxley Act of 2002, <font color="blue">the Securities </font>and Exchange     Commission <font color="blue">adopted rules</font> requiring <font color="blue">public companies</font> to include in their     annual reports an <font color="blue">assessment</font> of the <font color="blue">effectiveness</font> of the company’s internal     <font color="blue">controls <font color="blue">over financial</font></font> reporting</td>
    </tr>
    <tr>
      <td>In addition, the in<font color="blue">dependent</font> registered     <font color="blue"><font color="blue">public accounting firm</font> auditing</font> a public company’s <font color="blue">financial statements</font> must     attest to and report on <font color="blue">management</font>’s <font color="blue">assessment</font> of the <font color="blue">effectiveness</font> of the     company’s  internal  <font color="blue">controls <font color="blue">over financial</font></font> reporting, as well as the     operating <font color="blue">effectiveness</font> of the company’s <font color="blue"><font color="blue">internal controls</font> over</font> financial     reporting</td>
    </tr>
    <tr>
      <td>We evaluate our <font color="blue"><font color="blue">internal controls</font> over</font> financial reporting in     order to allow our <font color="blue">management</font> to report on, and our in<font color="blue">dependent</font> registered     <font color="blue">public accounting firm</font> to attest to, our <font color="blue">internal controls</font></td>
    </tr>
    <tr>
      <td>We expect to continue to expend <font color="blue">significant</font> resources in <font color="blue">complying with</font> the     <font color="blue">documentation</font> and <font color="blue">testing procedures</font> required by the Sarbanes-Oxley Act of     2002</td>
    </tr>
    <tr>
      <td>However, <font color="blue">there will remain</font> an <font color="blue">ongoing risk</font> that we will not comply     with all of its <font color="blue">requirements</font></td>
    </tr>
    <tr>
      <td>If our in<font color="blue">dependent</font> registered <font color="blue">public accounting firm</font> differs from us in its     <font color="blue">interpretation</font> of the <font color="blue">requirements</font> imposed on us by the Sarbanes-Oxley Act     of 2002, or if it is not satisfied with our <font color="blue"><font color="blue">internal controls</font> over</font> financial     reporting or with the level at which such controls are documented, operated     or reviewed, we may be delayed in filing reports with <font color="blue">the Securities </font>and     Exchange Commission, our in<font color="blue">dependent</font> registered <font color="blue">public accounting firm</font> may     decline to attest to our <font color="blue">management</font>’s <font color="blue">assessment</font> or it may issue a qualified     report</td>
    </tr>
    <tr>
      <td>In addition, if our in<font color="blue">dependent</font> registered <font color="blue">public accounting firm</font> is     unable  to  rely  on our <font color="blue"><font color="blue">internal controls</font> over</font> financial reporting in     <font color="blue">connection</font> with its audit of our <font color="blue">financial statements</font> and if it is unable to     <font color="blue">devise alternative procedures</font> in order to <font color="blue">satisfy itself as</font> to the material     accuracy of our <font color="blue">financial statements</font> and related <font color="blue">disclosures</font>, it is possible     that we could receive a qualified or <font color="blue">adverse audit opinion</font> in <font color="blue">connection</font>     with those <font color="blue">financial statements</font></td>
    </tr>
    <tr>
      <td>Accordingly, we may not receive a favorable report from our in<font color="blue">dependent</font>     registered <font color="blue">public accounting firm</font> regarding our <font color="blue"><font color="blue">internal controls</font> over</font>     financial reporting and the operating <font color="blue">effectiveness</font> of our <font color="blue">internal controls</font>     <font color="blue">over financial</font> reporting</td>
    </tr>
    <tr>
      <td>If we identify material <font color="blue">weaknesses</font> in our internal     <font color="blue">controls <font color="blue">over financial</font></font> reporting that we <font color="blue">cannot remediate</font> in a timely     manner or if we receive an adverse report from our in<font color="blue">dependent</font> registered     <font color="blue">public accounting firm</font> <font color="blue">with respect</font> to our <font color="blue"><font color="blue">internal controls</font> over</font> financial     reporting, investors and <font color="blue">others may lose confidence</font> in the <font color="blue">re<font color="blue">liability</font></font> of     our  <font color="blue">financial statements</font> and the market for our <font color="blue"><font color="blue">Common Stock</font> </font>could be     <font color="blue"><font color="blue">adversely</font> affect</font>ed</td>
    </tr>
    <tr>
      <td>Our <font color="blue">operations</font> are subject to <font color="blue">certain risks</font> and <font color="blue">uncertainties associated</font>     with  the  listing  in the <font color="blue">United Kingdom </font>of common stock of Spacelabs     Healthcare</td>
    </tr>
    <tr>
      <td>In October 2005, we announced the <font color="blue">initial public offering</font> in the United     Kingdom  of  13dtta5 million  <font color="blue">previously</font>  unissued shares of common stock     (<font color="blue">representing</font> <font color="blue">approximately</font> 20prca of its total issued and outstanding shares)     of Spacelabs Healthcare, a newly formed subsidiary composed of the business     <font color="blue">operations</font> of our Healthcare division</td>
    </tr>
    <tr>
      <td>These <font color="blue">shares currently trade under</font>     the <font color="blue">ticker symbol</font> “SLAB” on the Alternative Investment Market (AIM), a     market <font color="blue">administered</font> by <font color="blue">the London Stock Exchange</font></td>
    </tr>
    <tr>
      <td>The value of these shares,     and <font color="blue">consequently</font> the value of the shares in <font color="blue">Spacelabs Healthcare </font>that we     retained following the placing, is subject to stock price <font color="blue">fluctuations</font> as     well  as  <font color="blue">fluctuations</font> in the British pound, the currency in which the     <font color="blue">shares trade</font></td>
    </tr>
    <tr>
      <td>A downturn in the performance of <font color="blue">equity markets</font> in the United     Kingdom <font color="blue">generally</font>, or on the AIM specifically, could depress the value     of the <font color="blue">Spacelabs Healthcare </font>shares that we own</td>
    </tr>
    <tr>
      <td>27     ______________________________________________________________________    [55]Table of <font color="blue">Contents       </font>We receive <font color="blue">significant</font> amounts of research and <font color="blue">development</font> funding for our     security and <font color="blue">inspection systems</font> from <font color="blue">government</font> grants and contracts</td>
    </tr>
    <tr>
      <td>We may     not continue to receive <font color="blue">comparable levels</font> of funding for <font color="blue">future product</font>     <font color="blue">development</font></td>
    </tr>
    <tr>
      <td>The  US  <font color="blue">government</font> currently plays an <font color="blue">important role</font> in funding the     <font color="blue">development</font> of certain of our security and <font color="blue">inspection systems</font> and sponsoring     their deployment at airports, ports and <font color="blue">border crossings</font></td>
    </tr>
    <tr>
      <td>However, in the     future, additional research and <font color="blue">development</font> funds from the <font color="blue">government</font> may     not be available to us</td>
    </tr>
    <tr>
      <td>If the <font color="blue">government</font> fails to continue to sponsor our     <font color="blue">technologies</font> we may have to expend more resources on product <font color="blue">development</font> or     cease <font color="blue">development</font> of certain <font color="blue">technologies</font>, <font color="blue">which could</font> <font color="blue"><font color="blue">adversely</font> affect</font> our     business</td>
    </tr>
    <tr>
      <td>In addition, any <font color="blue">future grants</font> to our <font color="blue">competitors</font> may improve     their  ability  to develop and market competing products and cause our     customers to delay purchase decisions, <font color="blue">which could</font> harm our ability to     market our products</td>
    </tr>
    <tr>
      <td><font color="blue">Our Articles of Incorporation </font>and other <font color="blue">agreements contain provisions</font> that     <font color="blue">could discourage</font> a takeover</td>
    </tr>
    <tr>
      <td><font color="blue">Our Articles of Incorporation </font>authorize our <font color="blue">Board of Directors </font>to issue up     to 10cmam000cmam000 shares <font color="blue">of <font color="blue"><font color="blue">Preferred Stock</font> </font></font>in one or more series, to fix the     rights, <font color="blue">preferences</font>, privileges and <font color="blue">restrictions</font> granted to or <font color="blue">imposed upon</font>     any <font color="blue">wholly unissued shares</font> of <font color="blue">Preferred Stock</font>, to fix the number of shares     <font color="blue">constituting</font> any such series and to fix the <font color="blue">designation</font> of any such series,     <font color="blue">without further vote</font> or <font color="blue">action by <font color="blue">shareholders</font></font></td>
    </tr>
    <tr>
      <td>The terms of any series of     <font color="blue">Preferred Stock</font>, which may include priority claims to assets and dividends     and special voting rights, could <font color="blue"><font color="blue">adversely</font> affect</font> the rights of the holders     of our <font color="blue"><font color="blue">Common Stock</font> </font>and thereby reduce the value of our <font color="blue">Common Stock</font></td>
    </tr>
    <tr>
      <td>We     have no present plans to <font color="blue">issue shares</font> of <font color="blue">Preferred Stock</font></td>
    </tr>
    <tr>
      <td>The issuance of     Preferred  Stock,  coupled  with the <font color="blue">concentration</font> of ownership in the     <font color="blue">directors</font>  and  executive  officers, <font color="blue">could discourage</font> <font color="blue">certain types</font> of     <font color="blue">transactions</font> involving an actual or potential change in control of our     company, including <font color="blue">transactions</font> in which the holders of <font color="blue"><font color="blue">Common Stock</font> </font>might     otherwise receive a premium for their <font color="blue">shares over then current prices</font>,     <font color="blue">otherwise dilute</font> the rights of holders of <font color="blue"><font color="blue">Common Stock</font> </font>and may limit the     ability of such <font color="blue">shareholders</font> to cause or approve <font color="blue">transactions</font> which they may     deem to be in their <font color="blue">best interests</font>, all of <font color="blue">which could</font> have a material     adverse effect on the <font color="blue">market price</font> of our <font color="blue">Common Stock</font></td>
    </tr>
    <tr>
      <td>We have in place a     <font color="blue">stockholder rights</font> plan, adopted in 2000, under which our <font color="blue">shareholders</font> are     entitled to <font color="blue">purchase shares</font> <font color="blue">of <font color="blue"><font color="blue">Preferred Stock</font> </font></font>under certain <font color="blue">circumstances</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">stockholder rights</font> plan may have the effect of impeding or preventing     <font color="blue">certain types</font> of <font color="blue">transactions</font> involving a change in control of our company     that could be <font color="blue">beneficial</font> to the <font color="blue">shareholders</font></td>
    </tr>
    <tr>
      <td><font color="blue">Our Articles of Incorporation </font>limit the <font color="blue">liability</font> of its <font color="blue">directors</font>, which     may limit the remedies we or our <font color="blue">shareholders</font> have available</td>
    </tr>
    <tr>
      <td><font color="blue">Our Articles of Incorporation </font>provide that, pursuant <font color="blue">to the California </font>    Corporations Code, the <font color="blue">liability</font> of our <font color="blue">directors</font> for monetary damages shall     be eliminated to the <font color="blue">fullest extent permissible under</font> California law</td>
    </tr>
    <tr>
      <td><font color="blue">This     </font>is intended to eliminate the personal <font color="blue">liability</font> of a director for monetary     damages  in  an <font color="blue">action brought by us</font>, or in our right, for breach of a     director’s duties to us or our <font color="blue">shareholders</font> and may limit the remedies     available to us or our <font color="blue">shareholders</font></td>
    </tr>
    <tr>
      <td>This provision does not eliminate the     <font color="blue">directors</font>’ fiduciary duty and does not apply to <font color="blue">liabilities</font> for: (i) acts or     omissions that involve intentional misconduct or a knowing and culpable     violation of law; (ii) acts or omissions that a director believes to be     contrary to the <font color="blue">best interests</font> of our company or our <font color="blue">shareholders</font> or that     involve the absence of good faith on the part of the director; (iii) any     <font color="blue">transaction from which</font> a <font color="blue">director derived</font> an <font color="blue">improper personal benefit</font>;     (iv) acts or omissions that show a <font color="blue">reckless disregard</font> for the director’s     duty to the our company or our <font color="blue">shareholders</font> in <font color="blue">circumstances</font> in which the     director was aware, or should have <font color="blue">been aware</font>, in the <font color="blue">ordinary course</font> of     performing a director’s duties, of a risk of <font color="blue">serious injury</font> to our company     or our <font color="blue">shareholders</font>; (v) acts or omissions that <font color="blue">constitute</font> an unexcused     pattern of <font color="blue">inattention</font> that amounts to an <font color="blue">abdication</font> of the director’s duty     to  our  company or our <font color="blue">shareholders</font>; (vi) certain <font color="blue">transactions</font> or the     approval  of <font color="blue">transactions</font> in which a director has a material financial     interest; and (vii) expressly imposed by statute for approval of certain     improper <font color="blue">distribution</font>s to <font color="blue">shareholders</font> or <font color="blue">certain loans</font> or <font color="blue">guarantees</font></td>
    </tr>
  </tbody>
</table>